DNA-dependent protein kinase (DNA-PK) is a critical enzyme involved in the repair of double-strand breaks in DNA through the non-homologous end joining (NHEJ) pathway. DNA-PK inhibitors are compounds designed to block the activity of this enzyme, thereby impeding the repair process and potentially leading to the death of cancer cells that rely on DNA repair mechanisms to survive.
